ScholarIQanswers from OpenAlex

Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome

PaperCitations, authors & open-access status

Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome have?

ScholarIQcitation count

Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome has 54 citations in the OpenAlex counts ScholarIQ stores.

When was Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome published?

ScholarIQyear

Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome has 2005 year in the ScholarIQ index.

What is the open-access status of Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome?

ScholarIQoa status

Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome has closed oa status in the ScholarIQ index.

What is the DOI of Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome?

ScholarIQdoi

The DOI for Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome is on the source record.

What is the PMID of Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome?

ScholarIQpmid

The PMID for Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome is on the source record.

What is the OpenAlex record for Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome?

ScholarIQopenalex

The OpenAlex for Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial